Hospital
Magnolia Regional Medical Center
Magnolia Regional Medical Center was paid $553K by Medicaid between Jan 2018 and Sep 2020, across 77 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 16% of everything it billed.
33Billing provider infoMAGNOLIA REGIONAL MEDICAL CENTER
MAGNOLIA, AR 71753
MAGNOLIA, AR 71753
33aNPI1346248317assigned 07/13/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$553K
24GClaims40,532
24DCodes billed77
24AFirst – last monthJan 2018 – Sep 2020
Compared with peers
Next to other General Acute Care Hospital providers in Arkansas
Rank by total paid#38 of 49
Median peer was paid$2.62M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,081 | $187K | |
| 2019 | 15,780 | $220K | |
| 2020 | 10,671 | $145K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 16% | 3,139 | 656 | $90K |
| 80053 | Comprehensive metabolic panel | 10% | 3,525 | 2,870 | $56K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 10% | 912 | 814 | $56K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.5% | 5,288 | 4,240 | $36K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.8% | 382 | 322 | $32K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.8% | 1,238 | 965 | $21K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.8% | 141 | 127 | $15K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.7% | 1,801 | 1,485 | $15K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.5% | 1,344 | 1,150 | $14K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.5% | 436 | 417 | $14K |
| 36415 | Collection of venous blood by venipuncture | 2.3% | 2,116 | 1,714 | $13K |
| 71046 | Radiologic examination, chest; 2 views | 2.3% | 758 | 661 | $13K |
65 more codes
| 99283 | Emergency room visit (moderate) | 2.1% | 687 | $12K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.0% | 985 | $11K |
| 97001 | 1.9% | 225 | $10K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 472 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 787 | $9K |
| 82553 | 1.6% | 989 | $9K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.4% | 55 | $8K |
| 81001 | 1.4% | 2,435 | $8K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.4% | 178 | $7K |
| 82550 | 1.3% | 1,102 | $7K | |
| 80061 | Lipid panel | 1.1% | 630 | $6K |
| 84484 | 1.1% | 1,088 | $6K | |
| 71045 | Radiologic examination, chest; single view | 1.1% | 959 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 439 | $5K |
| 81025 | <1% | 651 | $5K | |
| 82962 | <1% | 701 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 551 | $4K |
| 83690 | <1% | 544 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 493 | $3K |
| 85730 | <1% | 828 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 68 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 212 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 55 | $3K |
| 85610 | <1% | 1,090 | $3K | |
| 71020 | <1% | 164 | $2K | |
| 82150 | <1% | 389 | $2K | |
| 86901 | <1% | 120 | $2K | |
| 73562 | <1% | 80 | $2K | |
| 83605 | <1% | 245 | $2K | |
| 87040 | <1% | 148 | $2K | |
| 80050 | General health panel | <1% | 49 | $2K |
| 83735 | <1% | 282 | $1K | |
| 86900 | <1% | 108 | $988.09 | |
| 83655 | <1% | 61 | $975.59 | |
| 86756 | <1% | 60 | $963.60 | |
| 80320 | <1% | 71 | $920.18 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 13 | $887.14 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 22 | $807.28 |
| 81003 | <1% | 330 | $790.80 | |
| 99284 | Emergency room visit (serious) | <1% | 106 | $778.09 |
| 87806 | <1% | 24 | $762.56 | |
| 84145 | <1% | 41 | $659.87 | |
| 73630 | <1% | 30 | $626.76 | |
| 87186 | <1% | 200 | $590.38 | |
| 73610 | <1% | 30 | $508.32 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 26 | $444.10 |
| 87081 | <1% | 39 | $323.27 | |
| 86850 | <1% | 79 | $319.64 | |
| 87088 | <1% | 86 | $315.20 | |
| 74018 | <1% | 19 | $303.39 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 118 | $242.54 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 15 | $241.82 |
| 83880 | <1% | 14 | $237.15 | |
| 71010 | <1% | 33 | $225.00 | |
| 87070 | <1% | 27 | $191.47 | |
| 86592 | <1% | 25 | $143.19 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 37 | $114.12 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 13 | $41.87 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 38 | $21.74 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 16 | $2.16 |
| 90686 | 0% | 12 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 12 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 15 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 17 | $0.00 |
| 97161 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJONES, REX (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Magnolia Regional Medical Center | Magnolia, AR | $150K |
| Magnolia Regional Medical Center | Magnolia, AR | $23K |
| Magnolia Regional Medical Center | Magnolia, AR | $13K |
| Magnolia Regional Medical Center | Magnolia, AR | $9K |
| Magnolia Regional Medical Center | Magnolia, AR | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.